Duality Advisers’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,784
| Closed | -$1.02M | – | 392 |
|
|
2024
Q1 | $1.02M | Buy |
34,784
+605
| +2% | +$17.7K | 0.1% | 321 |
|
|
2023
Q4 | $1.15M | Buy |
34,179
+1,591
| +5% | +$53.7K | 0.12% | 282 |
|
|
2023
Q3 | $1,000K | Buy |
32,588
+5,241
| +19% | +$161K | 0.12% | 289 |
|
|
2023
Q2 | $1.1M | Buy |
+27,347
| New | +$1.1M | 0.14% | 266 |
|
|
2023
Q1 | – | Sell |
-14,164
| Closed | -$547K | – | 713 |
|
|
2022
Q4 | $547K | Buy |
+14,164
| New | +$547K | 0.06% | 422 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$560K | – | 644 |
|
|
2021
Q3 | $560K | Sell |
10,000
-13,326
| -57% | -$746K | 0.04% | 433 |
|
|
2021
Q2 | $1.42M | Buy |
+23,326
| New | +$1.42M | 0.13% | 277 |
|
|
2021
Q1 | – | Sell |
-25,251
| Closed | -$1.51M | – | 662 |
|
|
2020
Q4 | $1.51M | Buy |
+25,251
| New | +$1.51M | 0.11% | 272 |
|